Capital Markets Update / State of the Economy
2024-05-21 12:00 - 13:15 (America/New_York)
FREE Webinar: Capital Markets Update / State of the Economy

Tuesday, May 21, 2024 | 12:00 p.m.-1:15 p.m.

Register Today for FREE!

Join us for this insightful webinar where we’ll dive into crucial topics shaping the financial landscape. Our experts will discuss M&A collaborations and deals, emerging technologies garnering funding and the impacts of the IRA. Plus, you’ll gain valuable insights into the upcoming 2024 election’s potential ramifications on the economy. Don’t miss this opportunity to stay ahead in today’s dynamic market environment. Topics include:

M & A Collaborations & Deals

Technologies that are being funded and those that are not

IRA and its Impacts

Upcoming 2024 Election

Speakers:

Keith Gaub

Vice President & Assistant TreasurerBristol Myers Squibb

Mr. Gaub oversees Capital Markets, Financial Risk Management, International Treasury & International Treasury Operations, Cash Leadership and Benefit Investments. Prior to joining BMS, he worked at Zoetis for nine years, most recently serving as Senior Director of Investor Relations, where he managed relationships with sell-side analysts and large institutional investors, in addition to supporting their CEO and CFO during earnings announcements.

Courtney Rickert McCaffrey

Global Insights LeaderEY Geostrategic Business Group

Ms. McCaffrey drives market-leading insight around geopolitics, corporate performance and political risk management. She leads the analysis of the annual EY Geostrategic Outlook and advises clients on how geopolitical developments may impact their companies’ operations and strategies, and how to manage political risks more proactively. She is also the co-author of a forthcoming book entitled Geostrategy by Design: How to Manage Geopolitical Risk in the New Era of Globalization.

Patrick Morley

Senior Managing Director Equity Capital MarketsLeerink Partners

Mr. Morley is a Senior Managing Director in Leerink Partners’ Equity Capital Markets group, advising private and public healthcare companies on the optimal strategy and tactics to achieve their financing goals. He joined the Firm in 2011 as a member of the Healthcare Investment Banking group before transitioning to his current role.

Philip Sclafani

PartnerPWC

Mr. Sclafani has deep experience supporting branded, biotech, generics, medical device and other healthcare companies. He leads high performing teams to address his clients most challenging issues across strategy, operations, digital & analytics, compliance and technology in the Pharma commercial organization, medical affairs, M&A / business development and other key functions.

Roel van den Akker

Pharmaceutical and Life Sciences Deals LeaderPWC

Mr. van den Akker is PwC’s Pharmaceutical and Life Sciences Deals Leader, with vast experience in transactions, deals, M&A and divestitures. He leads a team focused on helping pharma, life sciences and med tech companies win through deals and seamlessly capture value during acquisitions.

MODERATOR: Scott Megaffin

President & CEOAdiso Therapeutics

Leveraging his extensive experience as a biopharma senior executive, Mr. Megaffin has guided both public and private companies as CEO and Board Director. His deep knowledge spans a broad range of therapeutic areas, including immunology, inflammation, oncology, anti-infectives, pain, critical care and virology. He currently applies his expertise beyond Adiso by serving on the board of BioNJ and Adastra.

Whether you’re involved in M&A, technology, finance or in the broader economic landscape, this webinar offers valuable insights tailored to pique your interests and expertise. Click here to register at no cost.

Who should attend this webinar: This webinar is ideal for financial professionals, investors, business leaders, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy.

2024 BioNJ HR Conference
2024-06-18 08:30 - 15:30 | Kean University, 1000 Morris Ave, Union, New Jersey, 07083, United States
Flourishing at Work: Tools, Tips, and Trends

Tuesday, June 18, 2024 | 8:30 a.m.-3:30 p.m.

Kean University, 1000 Morris Ave., Union, NJ

This program is approved for 5.5 HR Certification Institute® (HRCI®) credits.

Join us for BioNJ’s 11th Annual HR Conference, taking place at Kean University on June 18. Come ready to connect with other life sciences HR professionals, learn from industry experts on issues affecting your organization and leave with best practices that will enable you to position your company and your employees for success.

Be part of the conversation. Knowledge is power and collaboration is crucial in creating new opportunities and growing the ecosystem.

Register Today

Become a Sponsor

Lynne Anderson, J.D.PartnerFaegre Drinker

Brenda BurnerDirector, Global CompensationMerck & Co.

Christopher CozicExecutive Vice President & Chief People OfficerGenmab

Andrew DicksonPrincipalMercer

D’Angelique DopsonDirector Total Rewards Human ResourcesShionogi

Debbie HartPresident & CEOBioNJ

Dawn KesslerDirector, Site HR Lead USGenmab

Stela LupushorChief-Reframer, Reframe.Work Inc. & Co-Author of “Humans at Work and Humanizing Human Capital”

Eileen McNeelyPh.D., M.S., R.N.Executive Director SHINE, Human Flourishing ProgramHarvard University

Sally PaullExecutive Vice President Chief Human Resource OfficerRegeneron

Betty Rivera-ManningRewards Business Partner/ US P&O Policy Lead Novartis

Derrick Swinton, Ph.D. Associate Dean for Research, Dorothy and George Hennings College of Mathematics, Science and TechnologyKean University

Lisha YangSenior Director, Head of Operations Data Science & AIGenmab

Come ready to gather new and creative ideas, strategies and tactics for how to navigate today’s HR challenges and opportunities in the life sciences sector.

Click here to register now. Registration is $195 for BioNJ Members and $295 for Future Members. To learn about Sponsorship opportunities, contact Cheri Hennessy at CHennessy@BioNJ.org or 609-890-3185.

Download Kean Campus Map

2024 BioNJ IT/Cyber Briefing Webinar
2024-06-27 12:00 - 13:15
FREE Webinar: De-Risking Cybersecurity forEmerging Life Sciences Companies

Thursday, June 27, 2024 | 12:00 p.m.-1:15 p.m.

Register Today for FREE!

Join BioNJ’s IT/Cybersecurity Awareness Committee on June 27 for a virtual discussion on “De-risking Cybersecurity for Emerging Life Sciences Companies.” Few industries are as heavily targeted by cybercriminals as life sciences. It’s easy to see why…given the immense value of Patient data, research, market insights and product information. And emerging life sciences companies face even greater risks, as they often have limited operational budgets for cybersecurity personnel and infrastructure.

During this content-dense webinar, we’ll hear from current life sciences CEOs, CFOs and CIOs about the real-world cybersecurity challenges facing emerging companies. Additionally, cybersecurity industry experts — including the FDA — will share some of the practical ways to address those challenges.

Register today and come ready to ask our experts questions.

Hear from These Thought Leaders

Jim AmbrosiniChief InformationSecurity OfficerCompassMSP

Susan BlumChief Financial OfficerMelinta Therapeutics

Daniel BurkeDivision Chief, Cyber OperationsOffice of Criminal InvestigationsU.S. Food and DrugAdministration

Paul FangSr. Director, InformationSecurity & ComplianceBeiGene

Randy MilbyCEO & ChairTharimmune

Mark PelligrinoSr. Vice PresidentChief Information OfficerInsmed

Chris RiosSr. Vice PresidentMarsh

ModeratorLarry SamilowCo-Founder & Managing DirectorVerve Group Consulting

Thank You to Our Sponsors

2024 BioNJ Manufacturing Briefing
2024-09-13 08:30 - 15:45 | Sanofi, 55 Corporate Dr, Bridgewater, New Jersey, 08807, United States
Building the Future: Advancing Capabilities, Technology and Talent for the Next Era of Biomanufacturing

Friday, September 13, 2024 | 8:30 a.m.-3:45 p.m. Sanofi, 55 Corporate Dr, Bridgewater, NJ

Registration is now closed for this event. We look forward to seeing everyone tomorrow at the program. Please contact Maria Carapucci at MCarapucci@BioNJ.org with any questions. Thank you.

Biopharma manufacturing has been evolving rapidly. Join us on September 13 for BioNJ’s Manufacturing Briefing where you’ll hear from and engage with thought leaders on timely and important topics affecting the industry.

AI & Digital Health Webinar
2024-09-26 12:00 - 13:30
The Path to Real Impact of AI on Healthcare and Life Sciences

Thursday, September 26, 2024 | 12:00 p.m.-1:30 p.m. | Virtual

REGISTER TODAY FOR FREE!

Join us on September 26 for a complimentary webinar, where leading industry experts will share insights into how they are leveraging AI and cutting-edge technology to drive innovation, expand access and enhance Patient outcomes. Don’t miss this opportunity to gain valuable knowledge from those at the forefront of transformative advancements.

Speakers Include:

Kiran DattaniCustomer SuccessTransformation, Strategy & Architecture Google Cloud

Mr. Dattani is a seasoned AI Specialist & Technologist with over 20 years of experience in the life sciences and pharmaceutical industries. He has a proven track record of driving AI & digital transformation, automation and data science initiatives for leading organizations like Pfizer and Google. Mr. Dattani’s expertise spans AI healthcare practice, enterprise architecture, cloud enablement, AI and data solution delivery. He has a passion for leveraging technology to improve Patient outcomes.

Seemi KazmiExecutive DirectorProduct Management, Digital HealthBristol Myers Squibb

Ms. Kazmi is Executive Director and Digital Health TA Lead for Cardiovascular and Neuroscience. She is responsible for defining digital health strategy and implementing innovative solutions across the pharma value chain, both in commercial and clinical development. Ms. Kazmi is responsible for the global roadmap of a portfolio of solutions that includes first-in-class AI-based algorithms for Patient identification and clinical decision support, biometric sensors/wearables for remote Patient monitoring, tools integrated into EMRs and novel digital biomarkers of disease.

Scott OgdenHead, AI LabsGenmab

Mr. Ogden heads up the AI Innovation Lab at Genmab, where he’s focused on bringing leading, novel solutions to the forefront of biotech. With a background in computation, Mr. Ogden has spent his working years building healthcare innovation teams across the different sectors, including payors and providers. He’s currently juggling his role at Genmab with working on his EMBA at Wharton, studying entrepreneurship. During the program, he will share some down-to-earth insights on how Genmab is using AI to push the envelope on the end-to-end drug development lifecycle.

Troy Sarich, Ph.D.Chief Commercial Data Science OfficerJohnson & Johnson Innovative Medicine

Dr. Sarich leads teams that leverage the power of artificial intelligence and machine learning, real-world evidence (RWE), digital health and precision medicine across J&J’s global regions and multiple therapeutic areas. During his nearly 20-year tenure at J&J, Dr. Sarich has delivered business transformation and Patient impact across the Innovative Medicine sector’s R&D and Commercial teams, including as Vice President, RWE, Global Head of R&D Strategy, founding co-chair and member of the J&J AI Council and in pivotal roles in the clinical development of INVOKANA® and XARELTO®.

BioNJ is building a Directory of AI Service Providers. If you are a BioNJ Member and fit into this category, send your company information to RBromberg@BioNJ.org!

2024 BioNJ C-Suite Summit
2024-10-10 07:30 - 16:30
THIS EVENT IS CLOSED TO THE MEDIA

An Inflection Point for Innovation in Life Sciences

Thursday, October 10, 2024 | 7:30 a.m.-4:30 p.m. Bridgewater Marriott, 700 Commons Way, Bridgewater, NJ

Register Today

Become a Sponsor

Against a backdrop of change, the biopharmaceutical industry – and the next wave of innovation – are at an inflection point. Join us to reflect on the state of innovation in life sciences and how companies can best navigate through this period of continued change.

TimeAGENDA

7:30 a.m. – 8:15 a.m.Registration & Networking Breakfast

8:15 a.m. – 8:20 a.m.

Welcome & Opening Remarks

Debbie Hart, President & CEO, BioNJ
Emer Leahy, MBA, Ph.D., President & CEO, PsychoGenics & Chair, BioNJ

TimeINNOVATION

8:20 a.m. – 8:50 a.m.

Keynote: The Next Wave of Innovation in Life Sciences
Life sciences leaders are navigating a period of exciting innovation. Novel modalities and mechanisms of action have helped the industry address previously stubborn unmet needs. Over the past 10 years, R&D spend has increased, the pipeline has become more diverse and new asset approvals have accelerated. Looking ahead, policy reforms (e.g., IRA), a rapid proliferation in technological resources (e.g., AI, mRNA platforms) and a rise in cross-company collaborations suggest further change and opportunity. Join us in reflecting on what the future of life sciences innovation holds, and implications for large cap pharma companies, biotechs and life sciences investors.

Brandon Parry, MBA, Sr. Partner, McKinsey & Company

8:50 a.m. – 9:45 a.m.

Panel: Harnessing Change to Deliver Impactful Innovation
Industry leaders will reflect on the state of innovation, expected industry shifts, latest thinking on development paradigms, portfolio shifts, the lasting implications of policy reforms, the impact of technological evolutions, talent priorities and more.

Garrett Ingram, President & CEO, Cipla Therapeutics
Will Lewis, MBA, J.D., Chair & CEO, Insmed
Clive Meanwell, M.D., Chair & Partner, Population Health Partners
Tarek Rabah, MBA, President & CEO, Otsuka Pharmaceuticals
Scott White, MBA, Chief Operations Officer, NA Innovative Medicine, Johnson & Johnson
Conversation Leader: Harriet Keane, Ph.D., Partner, McKinsey & Company

TimePOLICY

9:45 a.m. – 10:15 a.m.

Fireside Chat: Policy Uncertainties in an Election Year
The past 18 months have borne witness to a rapidly evolving policy landscape (including but not limited to the IRA, IP, BIOSECURE) – with expected evolutions on the horizon compounded by a tumultuous election season. With the presidential election just a few weeks away, this session will explore potential health policy changes and implications for industry leaders.

Hon. Jim Greenwood, Former Congressman & Former President & CEO, BIO
Heather Meade, Principal, EY
Conversation Leader: Lisa LeCointe-Cephas, J.D., Partner, Compliance & Investigations & Global Chair, Life Sciences Sector, DLA Piper

10:15 a.m. – 10:30 a.m.
Networking Break

TimeMARKET ACCESS

10:30 a.m. – 11:15 a.m.
Panel: Market Access & ReimbursementThe market access landscape is intricate and constantly evolving, with payers persistently refining their business models and strategies. This panel will explore the essential groundwork for securing optimal reimbursement and payer coverage, which are crucial for ensuring Patient access to treatments and, ultimately, improving Patient care. The panel will also address key issues manufacturers face including changing legislation, consolidation, M&A, gross to net and commercial launch planning.

Paul Hunter, Vice President, Market Access and Commercial Operations, Halozyme
Christopher Jackson, J.D., Managing Member, The Law Office of Christopher S. Jackson
Jake McDowell, Vice President, Head, Market Access, Pricing and Value, Partner Therapeutics
Conversation Leader: Tom Evegan, Principal, Strategy & Management Consulting; National Consulting Leader Life Sciences, RSM

TimeTALENT

11:15 a.m. – 12:00 p.m.
Panel: Topics in Talent: Attraction, Retention & DiversityIn the life sciences sector, talent development is crucial for fostering innovation and addressing complex challenges. Companies are focused on developing the next generation of talent by providing opportunities for education, training and mentorship. Additionally, there is a growing emphasis on upskilling and reskilling talent to leverage AI and other advanced technologies for greater efficiency and effectiveness. This discussion will explore key learnings from workplace evolutions and strategies companies can and must adopt such as equity.

Britt Byers, Executive Vice President, Human Resources NA, Kyowa Kirin
Vikki Conway, Sr. Vice President & Head, Human Resources, U.S., Teva Pharmaceuticals
Kiran Dattani, MPH, MBA, Customer Success, Transformation, Strategy & Architecture, Google Cloud Healthcare & Life Sciences, Google
Conversation Leader: Jan Campbell, Managing Partner Pharmaceuticals & Biotechnology, Korn Ferry

TimeRESEARCH & DEVELOPMENT

12:00 p.m. – 12:30 p.m.
Fireside Chat: Research & Development in Mental HealthWith Global Mental Health Day as the backdrop, this discussion features two pioneers in mental health research and development and will explore the challenges in developing therapeutics in the mental health space and how they can provide learnings in other areas.

Husseini Manji, M.D., F.R.C.P.C., Professor, Oxford University; Co-Chair, UK Govt MH Mission; Former Global Head, Neuroscience, Janssen/Johnson & Johnson
Conversation Leader: Emer Leahy, MBA, Ph.D., President & CEO, PsychoGenics & Chair, BioNJ

12:30 p.m. – 1:30 p.m.
Networking Lunch

TimeCOMMERCIALIZATION & PATIENT SERVICES

1:30 p.m. – 2:15 p.m.
Panel: Continued Evolutions in Go-to-Market Models Including Patient ServicesThe continued evolution of the go-to-market (GTM) commercial model in life sciences has been characterized by a shift from push to pull strategies, the development of novel roles that rethink traditional functional boundaries in a compliant manner, and a simplification of the customer interface. This talk will explore how these approaches can enhance and improve Patient access to treatments given the complex journey that is the Patient experience. Getting it right can have a major impact on Patient outcomes, as Patient experience in healthcare continues to lag. personalized journeys.

John Harlow, Chief Commercial Officer, Melinta Therapeutics
Rohan Jain, General Manager, Commercial, Nusano
Gina Murdoch, MBA, President & CEO, Multiple Sclerosis Association of America
Conversation Leader: Haripriya Jain, MS, MBA, Executive Director, Global Value & Access Consulting, Evidera, part of Thermo Fisher Scientific

TimeCAPITAL MARKETS

2:15 p.m. – 3:00 p.m.
Panel: Evolving Capital Markets & Implications for InnovationThe life sciences industry market cap has more than tripled in a decade despite more recent challenges. This discussion will explore the latest funding environment (e.g., IPOs) and implications for industry.

Aamir Mecklai, Managing Director, Healthcare Investment Banking, Bank of America
Christopher Mortko,MBA, Ph.D., Vice President, Business Development & Licensing, Merck & Co.
Monika Vnuk, M.D., Sr. Vice President, Global Partnering & Business Development, Sanofi
Conversation Leader: Arda Ural, MBA, Ph.D., Americas Life Sciences Sector Leader, EY

TimeAI & TECHNOLOGY

3:00 p.m. – 3:45 p.m.
Panel: The Digital & AI Era in the Biopharma Industry: How Can Companies Across Functions Transition from Hype Into Reality?In the current environment, the biopharmaceutical industry is experiencing a transformative shift towards digitalization and AI adoption, promising improved efficiency, innovation and Patient outcomes. However, for companies to transition successfully from the hype surrounding these technologies into tangible benefits, they must integrate digital and AI solutions across functions, prioritize data-driven decision-making and foster a culture of innovation and adaptability.

Sydney Klein, Chief Information Security Officer & Head of IT Core Services, Bristol Myers Squibb
Hisham Hamadeh, Ph.D., Sr. Vice President & Global Head, Data Science & AI, Genmab
Keith Koharski, MBA, Executive Director, Global Development IT, Regeneron
Deiva Ramachandran, Ph.D., Partner, Generative AI-Automation Practice Leader, Healthcare, Life Sciences, State & Local Government, IBM
Conversation Leader: Donna Conroy, Founder, CEO, SciMar ONE

Join us on October 10 for this important conversation. Registration is $695 for BioNJ Members and $895 for Future Members. (BioNJ is pleased to have maintained our pricing unchanged for the past three years.) Click here to register.

Thank You to Our Sponsors

Positioning Early Cell Therapy for Clinical Success: Mitigating Risk & Ensuring GMP Readiness
2024-10-22 12:00 - 13:00
Positioning Early Cell Therapy for Clinical Success: Mitigating Risk & Ensuring GMP Readiness

Tuesday, October 22, 2024 | 12:00 p.m.-1:00 p.m. | Virtual

REGISTER TODAY FOR FREE!

The promise of cell therapies is often tempered by the many complexities of transitioning these innovations from R&D to the clinic. For early phase programs, there are many aspects to consider, from understanding evolving regulatory guidelines and reviewimg pathway options to addressing common manufacturing-related issues such as scalability, high cost of goods, and workforce retention. Additionally, organizing and executing a successful cell therapy clinical trial can be challenged by a limited number of qualified clinical sites with experience in conducting advanced therapy studies, access to desired Patient populations, and managing the complex supply chain required to deliver therapies to Patients in a timely fashion.

Through a series of brief presentations on three key topic areas, this webinar will help early phase cell therapy developers identify insights to mitigate risk and ensure clinical readiness to position their programs for success.

Specific topic areas of focus include:

Navigating an evolving cell therapy regulatory landscape

How to assess GMP-readiness and prepare your cell therapy workflow for clinical and commercial manufacturing

Ensuring patient-centricity in the complex cell therapy ecosystem and leveraging a unique, comprehensive operating model for your product

Learning objectives:

Strategies to navigate regulatory hurdles and maximize impact of meetings with regulators

Best practices to address common challenges in cell therapy process development and manufacturing

Opportunities for a more streamlined, Patient-centric approach to cell therapy clinical trials

Benefits of working with an integrated CRO/CDMO partner to simplify the cell therapy value chain and improve Patient-centricity

Presenters:

Michele DugganSr. Manager, Regulatory AffairsThermo Fisher Scientific

Ms. Duggan joined Thermo Fisher Scientific in 2021 as Sr. Manager Regulatory Affairs supporting the development and delivery of regulatory solutions for customers within the biologics and advanced therapies pharma services manufacturing network. Prior to joining Thermo Fisher Scientific, she spent over 17 years in CMC regulatory consulting, providing regulatory strategy, dossier authoring and review expertise for biologics and cell therapy products across all stages of the product life cycle.

Mindy Sadik, Ph.D.Director, Cell Therapy SciencesThermo Fisher Scientific

Dr. Sadik oversees the Process Development and Analytical Development teams for the Cell Therapy Business unit for Advanced Therapies. Dr. Sadik’s teams work closely with partners to provide development and clinical scale services, which include gene and non-gene modified cell processing for autologous and allogeneic cell therapies. This work includes technology transfer from the client to Thermo Fisher’s site, process optimization and workflow readiness for transition into GMP manufacturing.

Kim Watanabe, Ph.D.Executive Director, Cell and Gene Therapy Pillar HeadThermo Fisher Scientific

Dr. Watanabe recently joined PPD, part of Thermo Fisher Scientific, where she leads business and operational strategy development and deployment in hematology and oncology clinical development services. She has 20 years of experience in R&D, business and operations, of which the last 14 years have been focused on cell and gene therapies. Prior to her current role, Dr. Watanabe served as General Manager and Site Head for the Patheon Translational Services. Prior to her current role, she served as GM/ Site Head for the Patheon Translational Services, part of the contract development and manufacturing organization of Thermo Fisher Scientific.

Register today and join us on October 22 for this FREE educational webinar. Come ready to learn and ask questions!

Life Sciences Alternative Funding Panel
2024-10-24 17:00 - 19:00
Join us at the New Jersey Bioscience Center for insights into alternative sources of funding to advance life sciences companies in New Jersey.

This panel discussion will focus on securing funding from non-traditional sources, and will address the following questions:

How will the next generation of drugs, diagnostics, and devices be funded?

What new models are there that might change the paradigm?

Is there a better way to fund early and emerging commercial biomedical research?

Panelists Include:

Josh Barer, Managing Director at Hibiscus BioVentures

Judith Sheft, Executive Director, NJ CSIT

Jorge Ramirez, Vice President, M&A and Business Development, Quest Diagnostics

Moderated by John Pennett, Partner, Life Sciences and Technology Group, Eisner Advisory Group LLC

Health Equity in Clinical Trials New Jersey Participant Demographics
2024-11-07 12:00 - 13:00
Webinar: Health Equity in Clinical TrialsNew Hersey Participant Demographics

Thursday, November 7, 2024 | 12:00 p.m.-1:00 p.m.

Register for FREE!

Be among the first to hear the findings in BioNJ’s newly published whitepaper, “Health Equity in Clinical Trials: New Jersey Participant Demographics,” presented in partnership with Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry.

Clinical trials represent a $15.2 billion industry in the U.S., with a continuing need for increased participation.

Therefore, this pioneering research tackles a critical goal: supporting the recruitment of underrepresented communities in clinical trials, specifically in New Jersey, while comparing New Jersey’s recruitment performance with similar states, such as Connecticut, Maryland, Massachusetts and New York.

Join us on November 7 as our experts share key findings, shed light on demographic recruitment variations across states and define crucial public policy opportunities to pursue more accurate demographic representation according to epidemiological data.

By attending, you’ll gain insights to help ensure that clinical trials more accurately reflect and serve the diverse populations they aim to benefit. Click here to register for free.

Hear from:

Caroline Der Nigoghossian, PharmD, MS, BCCCPSenior Clinical Engagement Lead Medidata AI LabsMedidata Solutions

Ian McLaughlin, Ph.D.Vice PresidentGovernment AffairsBioNJ

Evon Okidi, ScM, MSSenior Data ScientistMedidata Solutions

Click here to download a copy of “Health Equity in Clinical Trials: New Jersey Participant Demographics“.
https://lancewallnau.com

7th Annual Symposium for Life Science Innovation and Development
2024-11-12 08:00 - 15:00
***Not a BioNJ Hosted Event***

A Special Full-Day Conference for Life Science, Design and Real Estate Professionals

Bringing the life sciences innovation community together

Launched in 2018, NY Metro Builds Bio+ focuses on the growth and development of the life science cluster in the Greater New York Metro area (which includes New York City and the surrounding counties of New York, Connecticut, New Jersey and Pennsylvania). NY Metro Builds Bio+ hosts a series of events and educational initiatives and generates research and reports.

A 501(c)(3) nonprofit membership-driven organization, NY Metro Builds Bio+ is dedicated to bringing the life sciences innovation community together, serving as the go-to place to find information about and assistance with growing, building and locating life science companies in the New York Metropolitan area.Join us at the Seventh Annual Symposium for Life Science Innovation and Development to hear how private and public investments are driving exponential growth for the life science industry, what new initiatives are furthering innovation in the space and what this means for the Greater NY Metropolitan Area.The symposium will also highlight a new London/UK life sciences chapter and we’ll present the research report from the London life sciences study tour which took place in April 2024.

Click here for more information.

2024 BioNJ Patient Advocacy Summit
2024-11-14 08:30 - 15:00 | Bristol Myers Squibb, 3401 Princeton Pike, Lawrence Township, NJ, 08648, United States
The Power of the Patient’s Voice

Thursday, November 14 • 2024, 8:30 a.m.-3:00 p.m.

Bristol Myers Squibb • 556 Morris Ave, Summit, NJ 07901

Attendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.

Register Now

Become a Sponsor

Join us for this dynamic and educational discussion that will leave us all inspired and armed with new tools to make a difference on behalf of Patients!

BioNJ’s Patient Advocacy Summit will bring together Patients, Patient Advocacy Groups, Caregivers, Clinicians and R&D Professionals for a day of Education, Engagement and Empowerment. Attendees will gain valuable tools and insights, share best practices and meet key stakeholders within the health care ecosystem.

Attendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.

Thank You to Our Sponsor

2024 BioNJ AI & Digital Health Day
2024-11-18 09:00 - 16:30 | Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, New Jersey, 07030, United States
Register Today

Become a Sponsor

November 18, 2024 | 9:00 A.M. – 4:30 P.M.Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ

The event today is at the Tech Flex space in University Center Complex (UCC). You should have received an email from BioNJ which includes more details about the location and links to a campus map. The building is about halfway between the Howe Center and Babbio Center. Please plan to arrive early. Hoboken is congested in the morning, and it can take time to get to campus. We look forward to seeing you there!

Join BioNJ, in partnership with Morgan Stanley and DLA Piper and hosted by Stevens Institute of Technology, on November 18 for our 2nd Annual AI & Digital Health Day.

Featuring an exhilarating full-day program, we’ll:

Explore the latest trends in AI and digital health and how they are already impacting the life sciences industry

Dive into the challenges faced by entrepreneurs as they develop cutting-edge solutions to enhance Patient outcomes

Hear rapid-fire lightning pitches from entrepreneurial companies revolutionizing healthcare through AI-driven innovations (Interested in pitching? Click here to learn more and apply!)

Plus, entrepreneurs will have the opportunity to meet one-on-one to get advice from experts from financial, legal, investor and healthcare provider organizations at our Industry Help Desks.

Campus Maphttps://assets.ctfassets.net/mviowpldu823/1RHE112FrlUHseuZoPDsRM/a6feb431cdb732d2a565191de33dd298/Stevens-Campus-map-2024-web.pdf

Driving Directionshttps://www.stevens.edu/driving-directions-to-stevens

Visit Websitehttps://www.stevens.edu/admission-aid/visit-stevens

Parking Resources

*We recommend taking public transportation if you are able and leaving time to find parking*

Off-Campus ParkingThere may be parking spaces available on nearby city streets, but visitors should abide by the parking signs posted by the City of Hoboken. Parking in “Resident Only” spaces or on the side of a street scheduled for cleaning will result in a vehicle being ticketed, booted, or towed.

Hoboken Municipal Garages

Garage D at 215 Hudson St.

Garage D Parking | Find Parking | ParkMobile – this is the closest municipal parking lot to the University Center Complex at the Stevens Institute. Parking reservations can be made via this link.

Garage G at 315 Hudson St.

Hoboken Private Garages

River Street Garage at 333 River St.

Maxwell Place Garage at 1025 Maxwell Ln.

Independence Garage at 2 12th St.

Little Man Parking Garage at 225 River St.

The following apps might be helpful in reserving spots in these private garages:Search | Propark MobilitySpotHeroParkChirp

Register today and join an audience of entrepreneurs and industry professionals that support the life sciences and digital health ecosystem for this timely and informative discussion. Registration is $100 for BioNJ Members and $150 for Future Members. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities.

Thank You to Our Sponsors

BioNJ Finance Webinar
2024-11-21 12:00 - 13:15
Post-Election Insights: Navigating Economic, Tax & Policy Changes in Life Sciences

Thursday, November 21, 2024 | 12:00 p.m.-1:15 p.m.

Register for FREE

Join us for an engaging post-election webinar where industry experts will offer valuable insights into navigating the evolving landscape of economic, tax and policy changes impacting the life sciences sector. This informative session promises to provide you with the strategies and knowledge needed to stay ahead in these rapidly changing times.

Topics include:

Post Election Discussion and the Impact on the Economy and the Industry

Macro Environment & Trends

Tax & Policy Update

Don’t miss this opportunity to stay ahead in today’s dynamic environment.

Our Experts Include:

Taylor HittleSenior ManagerWashington CouncilEY

Fred GordonSenior DirectorWashington NationalRSM

Michael StrazzellaCo-ChairGovernment RelationsBuchanan Ingersoll& Rooney

Moderator:Sanjeev NarulaCFOIntra-Cellular Therapies

Whether you’re involved in M&A, technology, finance or in the broader economic landscape, this webinar offers valuable insights tailored to pique your interests and expertise. Click here to register at no cost.

Who should attend this webinar:

This webinar is ideal for financial professionals, investors, business leaders, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy.

Thank You to Our Sponsors

2024 BioNJ Inspiring Women in STEM Conference
2024-12-06 08:30 - 14:30 | Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, New Jersey, 07030, United States
Friday, December 6, 2024 | 8:30 a.m.-2:30 p.m.Sanofi U.S., 55 Corporate Drive, Bridgewater, NJ 08807

Register Today!

Become a Sponsor

Join us for BioNJ’s Tenth Annual Inspiring Women in STEM Conference on Friday, December 6, 2024. A thoughtfully curated agenda will allow participants to consider the most cutting-edge questions and essential and relevant topics of the day including Women’s Health Disparities, AI-enabled Women’s Health, and Powerful and Empowering Leadership, wrapping up with a C-Suite leadership panel that is sure to inspire. Audience participation exercises and quality networking will make this a meaningful experience leaving attendees with actionable insights designed to inform, involve and inspire. And this event promises to equip participants with the tools and ideas they need to impact their organizations.

TimeCheck Out the Agenda

8:30 a.m. – 9:00 a.m.
Registration & Networking Breakfast

9:00 a.m. – 9:15 a.m.
Welcome & Opening Remarks

Debbie Hart, President & CEO, BioNJ
Raquel Mura, Head, Global R&D Operations North America, Sanofi

Time BE INFORMED: EDUCATIONAL TOPICS

9:15 a.m.– 10:15 a.m.
Panel: Addressing Women’s Health Disparities and AdvocacyThis session will explore women's health disparities and advocacy efforts, offering an historical perspective to contextualize current challenges and advancements. Experts will discuss recent developments, upcoming trends and key areas for intervention, while collaborating on actionable steps to empower advocacy and drive meaningful change in women's health.Panelists:

Rachel Braun Scherl, Managing Partner & Co-Founder, SPARK Solutions for Growth
Elizabeth Garner, M.D., Former Chief Scientific Officer, Ferring Pharmaceuticals US, Immediate Past President, American Medical Women's Association
Denise Rodgers, M.D., Vice Chancellor, Interprofessional Programs, Rutgers University

Moderated by: Jen Radin, US Healthcare Advisory Sector Leader & Founding Partner, Deloitte Health Equity Institute, Deloitte

10:15 a.m.– 11:00 a.m.
Panel: AI & Advancing Women’s HealthOur experts will delve into how AI technologies are revolutionizing diagnostics, treatment options and personalized care for women worldwide. From predictive analytics to precision medicine, discover how AI is reshaping healthcare delivery, improving outcomes and promoting equity in women’s health initiatives.Panelists:

Nidhal Bouaynaya, Ph.D., Associate Dean, Henry M. Rowan College of Engineering, and Professor of Electrical and Computer Engineering, Rowan University
Brianna Brennan, Chief Innovation Officer, Ontrak Health
Kirthika Parmeswaran, Chief Executive Officer, Vital Start Health

Moderated by: Maureen Cruz, Ph.D, MPH., Director, Science, Regulation & Policy, Faegre Drinker Biddle & Reath LLP

11:00 a.m. – 11:15 a.m.
Networking Break & Exhibitor Showcase

Time BE INVOLVED: INTERACTIVE TOPICS TO PROMOTE ACTIONABLE TAKEAWAYS/STEPS FOR ALL

11:15 a.m. – 11:45 a.m.
Leading From Where You Are: Women’s Power Advocacy & InfluenceKeynote by: Alison Fragale, Ph.D., Speaker, Professor & Compulsive OrganizerHow can women confidently advocate for their careers and ideas? Dr. Fragale will answer with six key strategies that anyone, regardless of title, can use to speak up and influence effectively without being seen as "aggressive" or "self-promoting." She'll discuss the importance of setting long-term goals, excelling in performance, becoming an "other promoter," while developing your own narrative cultivating status and power and strategically saying yes or no.

11:45 a.m. – 12:00 p.m.
Introduce Workshop / Table Discussion Topics

12:00 p.m. – 1:00 p.m.
Lunch & Table Discussions/Workshop & Exhibitor Showcase

1:00 p.m. – 1:30 p.m.
Debrief on Table Discussions/Workshop

TimeBE INSPIRED: INSIGHTS TO INSPIRE

1:30 p.m. – 2:30p.m.
Panel: Women C-Suite Executive PanelJoin us for an inspiring panel where leaders will share their personal journeys and insights on navigating the C-Suite. You'll gain valuable perspectives on leadership, innovation and overcoming challenges in both corporate and entrepreneurial settings. Whether you're aiming to advance your career, reach the C-Suite or become an entrepreneur, this session offers invaluable lessons and inspiration from accomplished women shaping today’s business world.Panelists:

Jennifer D'Angelo, Chief Operating Officer & Executive Vice President, Healthcare, New Jersey Innovation Institute
Sandy Milligan, M.D., J.D., President, Research & Development, Laboratory Operations, IT & HR, Aspira Women's Health
Eileen Morrissey, Founder & CEO, MedifVU
Katie Sugarman, M.D., Senior Vice President & Head, Clinical Strategy, Genmab

Moderated by: Cecilia Fong, Director, Business Insights & Analytics, Genmab

2:30 p.m.
Closing Remarks

Thank You to Our Sponsors

Register today and plan to join us at the Inspiring Women in STEM Conference on December 6, 2024. Please share with colleagues and clients who can benefit from this informative program. Registration for BioNJ Members is $330 and $430 for Future Members. Bring your entire Team!

Click here or contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions.

BioNJ Gives Back: A Volunteer Opportunity to Help Patients
2024-12-10 00:00 - 23:59
Tuesday, December 10, 2024

An Exclusive BioNJ Member Event

During this year’s BioNJ Annual Dinner Meeting and Innovation Celebration, Will Lewis, the Chair and CEO of Insmed, former BioNJ Chair and recipient of the 2024 Dr. Sol J. Barer Award, delivered a heartfelt call to action. He urged our Members to consider actively engaging in community volunteering.

In response, on December 10, BioNJ will unite our Members for a collective giving initiative, “BioNJ Gives Back.” During this volunteer program, industry colleagues will have the opportunity to build a BioBear, design a Superhero cape and write a heartfelt card for pediatric Patients throughout the State.

BioNJ Member company representatives are invited to join us at either of our two volunteer locations to take part in this meaningful program. Member companies can send up to five participants at no charge*. Each participant will have the opportunity to build a BioBear, design a Superhero cape and write a card which will be presented to a pediatric charity at the conclusion.

Two Locations/Times to Choose from on December 10:

9:00 a.m.-11:00 a.m.Location: Insmed700 US 206Bridgewater Township, NJ 08807

Register for Insmed

2:00 p.m.-4:00 p.m.Location: Genmab, 777 Scudders Mill RoadPlainsboro, NJ 08536

Register for Genmab

We hope you will join us! Thank you for your consideration.If you’re having trouble registering, please contact Randi Bromberg at RBromberg@bionj.org.

*Registration is on a first-come, first-served basis. Each location is limited to 150 volunteers.

Superhero Sponsor $10,000

15 tickets (Each ticket is for one person to build a BioBear, design a Superhero cape and write a card.)

Company logo on all promotions and the BioNJ website

Logo on BioBear birth certificates

Photo opportunity with Patient organization leader as we present BioBears at the conclusion of the program at both sites

All participants will be invited to participate in a group photo

Exposure to media and legislators invited to the event (attendance not guaranteed)

BioBear Sponsor $5,000

10 tickets (Each ticket is for one person to build a BioBear, design a Superhero cape and write a card.)

Company logo on all promotions and the BioNJ website

Logo on BioBear birth certificates

All participants will be invited to participate in a group photo

Exposure to media and legislators invited to the event (attendance not guaranteed)

Host Sponsors

Superhero Sponsor

BioBear Sponsor

Contact Randi Bromberg at RBromberg@BioNJ.org for more information or to become a sponsor!
https://apothekebergheim.de

Securing the Future: Cyber Insurance, Data Privacy & FDA Perspectives for 2025
2025-01-23 12:00 - 13:15
Securing the Future: Cyber Insurance, Data Privacy & FDA Perspectives for 2025

Thursday, January 23, 2025 | 12:00 p.m.-1:15 p.m.

Register for FREE

Kick off 2025 with a comprehensive exploration of how cybersecurity risks are shaping the life sciences industry. As companies continue to innovate and bring groundbreaking therapies and products to market, staying ahead of rapidly evolving cybersecurity regulations and threats is more important than ever.

Join BioNJ’s IT/Cybersecurity Awareness Committee on January 23 for an engaging virtual discussion, “Securing the Future: Cyber Insurance, Data Privacy & FDA Perspectives for 2025.”

Our panel of experts will share valuable insights on these timely and critical topics:

FDA & Cybersecurity: Focus, expectations and enforcement plansgement, Finance and Procurement and Research & Development (R&D) Facilities Management

2024 Year-In-Review: Key trends in cybersecurity risks

2025’s New Law: Preparing for the New Jersey Data Privacy Act

Hear From These Thought Leaders:

Scott Christie, J.D.PartnerMcCarter & English

Katherine ClarkVice PresidentCyber Client AdvisorMarsh

Shane MoylanVice PresidentCyber InsuranceMarsh

Moderator Larry SamilowCo-Founder, Managing DirectorVerve Group Consulting
https://fullertonradiology.org

Don’t miss this opportunity to gain practical knowledge and ask your pressing questions. Register today!

2025 BioNJ Annual Dinner Meeting & Innovation Celebration
2025-02-06 16:45 - 21:30 | Hilton East Brunswick, 3 Tower Center Blvd, East Brunswick, NJ, 08816, United States
Thursday, February 6, 2025 | 4:45 p.m.-9:30 p.m. | Hilton East Brunswick

Become a Sponsor

Photo Gallery

Award Presentation byDr. Sol J. BarerFormer ChairCelgene Corp.ChairTeva Pharmaceutical

Dr. Sol J. Barer HonoreeJayne GershkowitzChief Patient AdvocateAmicus Therapeutics

John CrowleyPresident & CEOBiotechnology Innovation Organization

Husseini Manji, M.D.Professor, Oxford University; Co-Chair, UK Gov’t Mental Health Mission & Former Global Head, NeuroscienceJohnson & Johnson

ASCII

Grace ElineBrain Cancer Survivor& Founder, With Grace

Register today and join us for BioNJ’s 32nd Annual Dinner Meeting and Innovation Celebration, taking place Thursday, February 6, 2025, at the Hilton East Brunswick, where we’ll celebrate the extraordinary innovation happening in the Garden State.

As always, many surprises are in store for an evening of inspiration and camaraderie. Kicking off the start of the New Year, BioNJ’s Annual Dinner Meeting & Innovation Celebration features:

Networking with biopharmaceutical professionals, government officials, academic leaders and professional service providers

The presentation of the Dr. Sol J. Barer Award for Vision, Innovation and Leadershipby Dr. Barer himself to Chief Patient Advocate for Amicus Therapeutics Jayne Gershkowitz

The acclaimed Innovator Awards honoring 18 New Jersey companies that received a novel FDA drug approval in 2024

The presentation of the Heart of BioNJ Awards to Grace Eline, Brain Cancer Survivor and Founder of With Grace, and Dr. Husseini Manji, Professor at Oxford Univ., Co-Chair of the UK Gov’t Mental Health Mission and Formal Neuroscience Global Head at Johnson & Johnson

Keynote with President and CEO of the Biotechnology Innovation Organization John Crowley

A Cocktail Hour, Dinner Program and Dessert Reception

Don’t miss this memorable evening celebrating New Jersey’s life sciences ecosystem and the Patients who inspire us. Registration for BioNJ Members is $540 and $625 for Future Members. Reserve a table for your Team today. Visit www.BioNJ.org for more information.

*BioNJ has a new Membership Database. When registering, you will need to start by clicking “Create Account”. If you have an account, you’ll be prompted to reset your password. If not, you’ll need to create a new account. Call 609-890-3185 should you need assistance. Thank you.

Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship Opportunities, reserve a table and to place your organization in the spotlight.

The New Trump Administration: Employment Law Update of What You Need to Know Now!
2025-03-06 12:00 - 13:30
The New Trump Administration: Employment Law Update of What You Need to Know Now!

Thursday, March 6, 2025 | 12:00 p.m.-1:00 p.m. | Webinar

Register Today for FREE!

Much has happened in just the first few weeks of the Trump Administration. Many of the new directives directly impact the workforce and employee lifecycle. BioNJ is offering a FREE webinar to help our HR community understand the employment law aspects of these new developments. Join Lynne Anderson and her colleagues at Faegre Drinker for a discussion of how President Trump’s New Executive Orders impact HR.

Topics will include:

The immediate impact on DEI, the OFCCP, the EEOC, AI and other workforce implications

How the recent changes to immigration policies impact the workplace.

What to expect regarding independent contractor classifications, non-competes and what is happening with the NLRB

How New Jersey and other State laws need to be considered in tandem with the new Trump Executive Orders and policy developments

*BioNJ has a new Membership Database. When registering, you will need to start by clicking “Create Account”. If you have an account, you’ll be prompted to reset your password. If not, you’ll need to create a new account. Call 609-890-3185 should you need assistance. Thank you.

Speakers:

Lynne Anne AndersonPartnerFaegre Drinker

Ms. Anderson is an experienced trial lawyer and strategic counselor with a long history of working with life sciences clients on all aspects of the employment relationship. She leads the firm’s Pay Equity Team and co-leads its Affirmative Action Task Force. Ms. Anderson has received multiple recognitions including by Chambers USA as a “Leading Lawyer for Business”. She Co-Chairs BioNJ’s HR and Inspiring Women of STEM Committees; is a member of Faegre Drinker’s Health & Life Sciences Industry Team and Co-Chaired the firm’s ERG, Women Forward, from 2011 to 2023.

Beth CarlsonPartnerFaegre Drinker

Ms. Carlson is an experienced business immigration lawyer with over 25 years of experience moving corporate talent across borders and counseling U.S. and international companies on complex immigration issues across all industries, including life sciences. She manages all types of U.S. employment-based immigration matters and leads the firm’s immigration team. Ms. Carlson also advises clients on changes to government policy, including continued heightened scrutiny from USCIS, the Department of Labor and other government agencies.

Brian HayesAssociateFaegre Drinker

Mr. Hayes counsels clients on a variety of employment-related issues, including discrimination, harassment, retaliation, wage and hour claims, employee mobility and trade secrets, breach of contract and defamation. He has deep experience advising clients on severance and release agreements, restrictive covenants and trade secrets, worker classification, creating employee handbooks and policies, reductions in force, leaves of absence, wage and hour compliance and other employment law developments.

Don’t miss this important discussion. We hope to see you on March 6, for this FREE educational webinar! Click here to register.

2025 BioNJ Legal Compliance & Regulatory Forum Webinar
2025-05-20 12:00 - 13:30
AI for Legal, Regulatory & Compliance Professionals

Tuesday, May 20 | 12:00 p.m.-1:30 p.m. | Webinar

Register Today for Free!

Please join us for a robust conversation focused on demystifying AI, with insight from academia, as well as legal and technology experts.

The panel will:

Provide a basic understanding for executives of ‘What is AI?’

Distinguish AI from data analytics from an education and technology perspective

Discuss AI and data analytics expectations as included in the September 2024 U.S. DOJ Evaluation of Corporate Compliance Programs (ECCP) update and General Compliance Program Guidance (GCPG)

Provide examples of ‘where to start’, how biopharma companies have begun to utilize AI tools and what may be on the horizon

Discuss how agencies, such as the Department of Justice, FDA and Veterans Affairs have begun to deploy AI tools

Share best practices for identifying and managing risks

Outline anticipated changes to regulations and expectations with the Trump Administration

Panelists:

Rachel BatykeferVice PresidentCIA & Compliance OperationsMallinckrodt Pharmaceuticals

Jacob Elberg, J.D.Professor of LawFaculty Director, Center for Health & Pharma LawSeton Hall University School of Law

Jeremy OsinskiPrincipalForensic & Integrity ServicesErnst & Young

Adam Solander, J.D.PartnerKing & Spalding

ModeratorLisa Dwyer, J.D.PartnerKing & Spalding

Join us virtually for this important conversation on May 20. Registration is open and free!

BioNJ has a new Membership Database. When registering, you will need to start by clicking “Create Account”. If you have an account, you may be prompted to reset your password. If you do not have an account, you’ll need to create one. If you need assistance, please call 609-890-3185. Thank you.

2025 BioNJ HR Conference
2025-06-05 08:30 - 15:00 | Kean University, 1000 Morris Ave, Union, New Jersey, 07083, United States
Adapt & Advance Amidst Ambiguity…Again

Thursday, June 5, 2025 | 8:30 a.m.-3:00 p.m.

Kean University | North Avenue Academic Building | 1000 Morris Ave., Union, NJ

BioNJ is recognized by SHRM to offer Professional Development Credits (PDCs) for SHRM-CP® or SHRM-SCP® recertification activities. This program is approved for 4 SHRM credits.

Registration is now open for BioNJ’s 12th Annual HR Conference taking place at Kean University on June 5. Come ready to connect with other life sciences HR professionals, learn from industry experts on issues affecting your organization and leave with best practices that will enable you to position your company and your employees for success.

Join the BioNJ HR community for answers, insights and a chance to contribute. Knowledge is power and collaboration is crucial in creating new opportunities and growing the ecosystem.

Register Today

Become a Sponsor

Come ready to gather new and creative ideas, strategies and tactics for how to navigate today’s HR challenges and opportunities in the life sciences sector.

Click here to register now. Registration is $195 for BioNJ Members and $295 for Future Members. To learn about Sponsorship opportunities, contact Cheri Hennessy at CHennessy@BioNJ.org or 609-890-3185.

Download Kean Campus Map

Clinical Development Webinar
2025-06-26 12:00 - 13:30
Master Protocols in Clinical Trials: Driving Innovation, Efficiency & Patient-Centric Research

Thursday, June 26 | 12:00 p.m.-1:30 p.m. | Webinar

Register Today for Free!

Master Protocols in Clinical Trials

“Master protocols are innovative clinical trials designed with multiple sub-studies, subgroup-populations, and subprotocols. They aim to explore or evaluate multiple therapies or multiple subpopulations in parallel under a single overarching protocol, with the characteristics of improving efficiency and establishing uniformity through standardization of procedures in clinical trials. Master protocols could help address scientific, operational, and competitive challenges in the existing drug development model.” ~AppliedClincialTrialsOnline.Com

Join us for an insightful FREE webinar exploring how Master Protocols are transforming the clinical trial landscape. Designed to increase efficiency and flexibility, Master Protocols offer a unified approach to studying multiple therapies, diseases or Patient subgroups under a single overarching framework.

In this session, you’ll:

Gain efficiency with Master Protocol

Optimize resource allocation

Streamline trial execution

Accelerate drug development

Expand quickly across indications

Support multiple launches

Enhance Patient journey

Encourage sub-studies within the same trial to assess variations of Patient treatment options

Balancing innovation around validity and relevance with Patient-centered approaches

Learning objectives include:

Define the Master Protocol in drug development

Outline key elements of a successful Master Protocol

Articulate the regulatory considerations related to the FDA Guidance on Master Protocols

Adapt the Master Protocol design for oncology to other therapeutic areas

Whether you’re a clinical operations professional, researcher or sponsor, this webinar will equip you with strategic insights to drive innovation while keeping Patients at the center of trial design.

Speakers

Lincy George, PharmD, Vice President, Global Regulatory Affairs, Oncology, Specialty Care Business Unit, Sanofi

Dr. George is a seasoned regulatory affairs professional with more than 20 years’ experience in large global pharmaceutical companies securing drug approvals for several high priority brands. She has broad cross functional experience with diverse teams in both development and commercial organizations, working on launch brands as well as products in development.

Bradley Smith, Ph.D., Vice President, Translational Medicine, IQVIA

Dr. Smith is a recognized leader in biomarker and companion diagnostic development, bringing deep experience across laboratory research, clinical implementation and Patient care. He is a subject matter expert in drug and diagnostic strategy, leading commercial planning and the integration of companion diagnostics in oncology and other therapeutic areas. His responsibilities include regulatory, technical and scientific oversight ― including U.S. registration.

Katherine Sugarman, M.D., Senior Vice President, Clinical Development Strategy, Genmab

Dr. Sugarman possesses a wealth of experience and expertise in oncology clinical development, both from academia and the pharmaceutical industry. As part of Genmab’s ongoing evolution in R&D, Dr. Sugarman oversees the clinical development strategy of their pipeline, ensuring strategic trial design, and providing scientific, medical and statistical analysis insights for the interpretation of clinical data to drive promising molecules forward to address high unmet medical needs for Patients.​

Moderator: Prasad Subramaniam, Ph.D, PMP, sMBA, Associate Director, Portfolio & Program Management, Genmab

Dr. Subramaniam is currently Associate Director within the Development Program Management function at Genmab, supporting late-stage oncology and hematology programs. He is an experienced drug development leader with over 12 years of combined academic and industry experience spanning program and stakeholder management, product development and strategic insights and competitive intelligence across hematology, immuno-oncology and solid tumors.

Chris Pullion, DO, Medical Director, Soligenix

Dr. Pullion oversees Soligenix’s study protocol design and implementation, safety and pharmacovigilance; assists with clinical operations and regulatory interactions; and reviews all study related reports, assessments and data analysis. He has been the clinical lead on numerous research programs over the years, including most recently Soligenix’ two Phase 3 studies where he oversaw everything from protocol design and conception through to drafting clinical study reports and preparation for new drug applications.

Don’t miss this opportunity to advance your understanding of the future of clinical trials. Click here to register for free and join us on June 26!

From Price Controls to Production Lines: How Policy Is Reshaping Biopharma Strategy
2025-07-31 09:30 - 11:00
Webinar: From Price Controls to Production Lines: How Policy Is Reshaping Biopharma Strategy

Thursday, July 31 | 9:30 a.m.-11:00 a.m. | Free to BioNJ Members

REGISTER TODAY!

BioNJ and Manatt Health invite you to a high-impact webinar exploring how today’s policy environment is transforming the economics, strategy and logistics of bringing therapies to market. With federal action on drug pricing reform and pharmaceutical supply chain security accelerating, life sciences leaders must adapt to a new set of constraints — and opportunities.

This session will bring together legal, policy and market experts to examine how the policies like the Inflation Reduction Act (IRA), the Most-Favored Nation Executive Order, Budget Reconciliation and the BIOSECURE Act are reshaping drug development timelines, manufacturing strategies and commercialization risk. From pricing pressures and exclusivity reform to reshoring incentives and funding models, we’ll explore how business leaders can position their organizations for resilience and growth.

Key Takeaways: Whether you’re charting policy risks, optimizing your supply chain or planning for long-term growth, this webinar will provide the strategic context and actionable guidance you need to stay ahead.

Topics

Drug Pricing Reform

How IRA implementation, MFN-style pricing and reconciliation policy are impacting pricing dynamics

The exclusivity debate and its implications for innovation, especially in rare diseases

The evolving role of PBMs and pending legislative reforms aimed at transparency and cost control

Supply Chain Resilience

The risks of global dependencies and policy moves to strengthen U.S.-aligned manufacturing

Opportunities and challenges in reshoring and rebalancing biopharmaceutical production

Quality, cost and sourcing trade-offs in a geopolitically complex landscape

New federal funding pathways and financing models to support domestic production

Emerging risks from proposals like “Pharma-Ron” and how to engage proactively

Integrated Business Strategy

Why commercialization, sourcing, manufacturing and logistics planning must be aligned with evolving policy

How to build resilience across the value chain — from pricing strategy to Patient delivery

Speakers

Nicholas W. Bath, Jr.PartnerManatt Health

Michael S. KolberPartnerManatt Health

Melindah SharmaManaging DirectorManatt Health

Whether you’re a CEO, SVP, Commercial Ops lead, legal advisor or corporate affairs executive, this session is designed to provide the strategic clarity you need to navigate today’s challenges — and tomorrow’s opportunities.

Register today and join us on July 31 for this must-attend webinar on biopharma policy shifts. Registration is FREE to BioNJ Members and $75 for Future BioNJ Members.

2025 BioNJ Manufacturing Summit
2025-09-10 09:00 - 15:45 | BeOne Medicines, 311 Pennington Rocky Hill Rd, Pennington, New Jersey, 08534
Navigating the Evolving Biopharma Landscape

With Insights from McKinsey & Co.

Wednesday, September 10, 2025 | 9:00 a.m.-3:45 p.m.BeOne Medicines, 311 Pennington Rocky Hill Rd, Pennington

Registration is now closed for this event. We look forward to seeing confirmed registrants Wednesday at the program. Please contact Danielle Campay at DCampay@BioNJ.org with any questions. Thank you.

Become a Sponsor

BioNJ’s Manufacturing Summit offers valuable insights from thought leaders on timely and important topics affecting the industry, such as microeconomic considerations for biopharma manufacturing, supply chain: onshoring impacts, workforce solutions and manufacturing innovation solutions.

As a special highlight, attendees will also enjoy a guided tour of BeOne’s state-of-the-art manufacturing facility — offering a firsthand look at innovation in action.

Our Speakers

Zainab Alali, Ph.D.Director, Biotechnology & Aseptic ManufacturingRaritan ValleyCommunity College

Remy Brim, Ph.D.Principal and Health & Life Sciences Practice LeadBGR Group

Joananne CoffaroVice PresidentExternal Affairs, Communication & AdvancementMiddlesex College

Cortney FarrellLaboratory Sales SpecialistDyna-Tech

Aaron R. Fichtner, Ph.D. PresidentNew Jersey Council of County Colleges

Sean Goudy, Ph.D., PE,Vice PresidentSite Leader & General ManagerFerring Pharmaceuticals

Debbie HartPresident & CEOBioNJ

Matt HohorstVice PresidentARCO Design/Build

Rich LoughlinChief Commercial Office & Board MemberCMIC CMO USA

Mike MaurerVice President & General Manager of U.S. ManufacturingBeOne Medicines

Conrad MercuriusExecutive Director, Workforce Development & Career EducationRaritan Valley Community College

Jeff MorellAssociate PartnerMcKinsey & Company

Fernando Muzzio Ph.D.Distinguished Professor of Chemical and Biochemical EngineeringRutgers University

Gonzalo Perez, Ph.D.Assistant Vice President for Academic AffairsMercer County Community College

Jason RadfordSenior Vice PresidentStrategic PartnershipsBeOne Medicines

Catherine Starghill, Esq.Vice PresidentNew Jersey Council of County Colleges

Derron StarkPartner, Principal Strategy & TransactionsEY

Norm StoffregenSenior Vice PresidentU.S. Site HeadEnzene

Tom SullivanExecutive Vice PresidentCBRE-Advisory & Transaction Services/Life Sciences Group

John TomtishenManufacturing Committee Co-ChairBioNJ

Michael Vreeland, MSU.S. Site Head & Interim Head of U.S. Process DevelopmentProBio

Thank You to Our Sponsors

Join us on September 10 for this important conversation. Registration is $125 for BioNJ Members and $250 for Future Members. Click here to register.

2025 Life Sciences at a Turning Point: Surviving & Thriving Amid Tariffs, Tax Policy & Capital Shifts
2025-09-12 09:00 - 10:30
Life Sciences at a Turning Point: Surviving & Thriving Amid Tariffs, Tax Policy & Capital Shifts

Friday, September 12, 2025 | 9:00 a.m.-10:30 a.m. | Webinar

Register Today!

Global policy shifts and market volatility are creating new challenges for biotech and pharma leaders. Get ahead of what’s coming with expert commentary on U.S. economic policy, international trade dynamics and capital markets.

Topics include:

Also hear how industry finance leaders are responding to it all

An update on the latest status of the US macroeconomy, including the strength of the labor market

The prospects for inflation returning to its 2% target level

The outlook for the Fed’s rate policy

Don’t miss this opportunity to stay ahead in today’s dynamic environment.

Our Experts Include:

Sara BonsteinChief Financial Officer Insmed

Ned HuxTax PartnerPwC

Numi PrasadManager, Health Industries Risk & Regulatory AdvisoryPwC

Philip SclafaniAdvisory Partner PwC

David Wilcox, Ph.D.Senior FellowPeterson Institute for International Economics

MODERATORMichael LoschChief Financial Officer Signum Biosciences

Who should attend this webinar:

This webinar is ideal for financial professionals, investors, business leaders, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy.

Register today and join us for this must-attend webinar. Registration is FREE to BioNJ Members and $75 for Future BioNJ Members. Click here to register.

Thank You to Our Sponsors

2025 BioNJ IT/Cyber Briefing Webinar
2025-09-17 12:00 - 13:30
Creating a Cybersecurity Culture in Life Sciences: Executives, Employees & IT Team Up to Protect Innovation

Wednesday, September 17, 2025 • 12:00 p.m.-1:30 p.m. | Webinar

Register Now

In today’s rapidly evolving digital landscape, cybersecurity is no longer just the responsibility of the IT department—especially for life sciences companies, where sensitive patient data, intellectual property (IP), and critical infrastructure are at stake.

Creating a strong cybersecurity culture is a shared, organization-wide responsibility. Executives must understand the risks and budget accordingly. Employees must embrace training and best practices. And IT must implement and uphold standards across the enterprise and with third-party vendors.

That’s why BioNJ’s IT/Cybersecurity Awareness Committee invites you to join us for an engaging and practical webinar, “Creating a Cybersecurity Culture in Life Sciences: Executives, Employees and IT Team Up to Protect Innovation.”

During this session, you’ll hear from a panel of industry experts who will explore:

The Executive’s Role: Why cybersecurity must be championed from the top, how to align it with business objectives, and how leadership can model secure behaviors that make security a core business value — not just a compliance checkbox.

The Employee’s Role: Why ongoing awareness and training are essential, especially around phishing, password hygiene, data handling and incident reporting.

The IT Perspective: How IT can support organizational goals while implementing best practices, managing vendor risk, and scaling cybersecurity cost-effectively — even with limited resources.

Our panel will share real-world success stories and practical, scalable strategies —including how to leverage automation and existing tools to build a resilient security culture, even in high-growth environments.

Jim AldridgeSenior Vice PresidentCybersecurity AdvisorMarshEmployee Perspective

Scott MegaffinPresident & CEOAdiso TherapeuticsExecutive Perspective

Sam Pierre-Louis, Ph.D.Senior Vice President & Chief Information OfficerAmicus TherapeuticsIT Perspective

Larry SamilowCo-Founder & Managing DirectorVerve Group ConsultingModerator

Don’t miss this opportunity to gain practical knowledge and ask your pressing questions. Register today! Registration is FREE to BioNJ Members and $75 for Future BioNJ Members.

Thank You to Our Sponsors

2025 AI & Digital Health Day
2025-10-09 08:30 - 16:15
Catalyzing Responsible Al Adoption Across New Jersey’s Life Sciences Ecosystem!

Thursday, October 9, 2025 | 8:30 a.m. – 4:15 p.m.Princeton University, Friend Center | 65 Olden St, Princeton, NJ 08540

Registration is now closed for this event. We look forward to seeing confirmed registrants Thursday at the program. Please contact Danielle Campay at DCampay@BioNJ.org to be added to the wait list. Thank you.

Become a Sponsor

Join BioNJ — alongside Morgan Stanley and DLA Piper, and hosted by Princeton Precision Health at the Princeton University Friend Center — on October 9 for our Third Annual AI & Digital Health Day. This high-impact, full-day event brings together industry leaders, trailblazing startups, regulatory voices and technology innovators to dive into real-world AI applications that are transforming biopharma today.

With New Jersey leading the charge in AI-driven life sciences innovation, don’t miss your chance to gain practical insights, build powerful connections and walk away with strategies you can apply immediately across your organization.

Please note: While our speakers will be sharing valuable insights. Their remarks are intended for informational purposes only and should not be considered official advice, guidance or endorsement.

Space is limited. So register today. Registration is $225 for BioNJ Members and $325 for Future Members. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Don’t miss this unique opportunity to gain critical insights, build powerful connections, and position yourself at the forefront of AI and digital health innovation.

Chris AbrahamAI LeadEmerging TechnologiesInsmed Incorporated

Mahiuddin Ahmed, Ph.D.President & Chief Scientific OfficerVITRUVIAE

Shervin AyatiBusiness Development ExecutiveIBM Research

McClain BrownAI GTM LeaderGoML

Meng Cao, Ph.D.Associate DirectorEngineering & Data SciencePsychoGenics

Diego Chowell, Ph.D. Assistant ProfessorIcahn School of Medicine at Mount Sinai

Christopher ColucciVice President Information TechnologyInsmed

Aruna DontabhaktuniCo-Founder & CEORegKey

Maureen EnnisCEOThrive Digital Era

Lauren GadsbyDirector of Global Digital HealthJohnson & Johnson

Hisham Hamadeh, Ph.D.Senior Vice President & Global Head, Data, Digital & AIGenmab

Debbie HartPresident & CEOBioNJ

Paul Howard, Ph.D.Executive DirectorPublic Policy &Corporate AffairsAmicus Therapeutics

Jae KimFDA PartnerDLA Piper

John MakiCEOSerotonix

Mary Maples, Esq.Deputy Chief Executive OfficerNew Jersey Economic Development Authority

Elizabeth McNeilly, CFPExecutive DirectorPrivate Wealth AdvisorAlternative Investments DirectorPortfolio Management DirectorMorgan Stanley

Scott OgdenHead of AI LabsGenmab

Yuri Ostrovsky, Ph.D.DirectorAI SolutionsOM1

Rob OttTeam LeadAI/Digital Health & EntrepreneurshipBioNJ

Mark Parsonson, CFAManaging DirectorHealthcare Investment BankingMorgan Stanley

Sarah PittmanExecutive Director Market ExecutiveMorgan Stanley

Emilio RagosaPartner & Managing PartnerShort Hills OfficeDLA Piper

Deiva Ramachandran Ph.D.Generative AI Practice LeaderIBM Consulting

Corey SandersSenior Vice PresidentStrategyCoreWeave

Guillermo Sapiro, Ph.D.Augustine Family Professor, Electrical & Computer EngineeringPrinceton Precision Health

Ellington WestCEO & Co-FounderSonavi Labs

Click Here for Visitor Parking & Transportation

Thank You To Our Sponsors

2025 BioNJ C-Suite Summit
2025-10-30 07:30 - 14:30 | Bridgewater Marriott, 700 Commons Way, Bridgewater, New Jersey, 08807, United States
Life Sciences Leadership Through Uncertainties

Thursday, October 30, 2025 | 7:30 a.m.-2:30 p.m.Bridgewater Marriott , 700 Commons Way, Bridgewater

Registration is $695 for BioNJ Members and $895 for Future Members

Register Today!

Become a Sponsor

Biopharma leaders are navigating through a period of evolving dynamics marked by AI-driven acceleration in advancing breakthroughs in therapeutics and commercial capabilities against a backdrop of compressed product lifecycles, mounting macroeconomic headwinds and disruptions in geopolitical order.

Join BioNJ and industry leaders on October 30 to explore these converging forces, exchange proven resilience strategies and chart a course for sustaining innovation and growth in even the most unpredictable environments. With dedicated networking sessions built into the program — including opportunities to connect directly with speakers — this event is designed to foster meaningful dialogue and lasting connections among C-Suite leaders and industry innovators.

Liz BarrettCEOUroGen Pharma

Mark CampbellCEOCivia Health

Michael Cantor, M.D. Vice PresidentData Technology & InnovationRegeneron

Brian CurciAssociate PartnerData & Agentic AI Leader, Life Sciences & HealthcareIBM

Nick Downing, M.D.Managing DirectorBain Capital Life Sciences

Marc FogartyPartnerEisnerAmper

Nick GarlowManaging DirectorRational 360

Laurie GeryHead, Business Development& Licensing, VaccinesSanofi

Hisham HamadehSenior Vice President Global Head of DataDigital & Artificial IntelligenceGenmab

Debbie HartPresident & CEOBioNJ

Ashutosh KatiyarExecutive DirectorCommercial Insights& AnalyticsOphthalmologyRegeneron

Matthew B. Klein, M.D., M.S., F.A.C.S.Chief Executive OfficerPTC Therapeutics

John KoufosPresidentCottage Four Strategic Solutions

David Kuninger, Ph.D. Director, R&DThermo Fisher Scientific

Emer Leahy, Ph.D., MBAPresident & CEOPsychoGenics & Chair, BioNJ

Evan LippmanExecutive Vice PresidentBusiness DevelopmentTeva Pharmaceuticals

Clive Meanwell, M.D., Ph.D.ChairmanPopulation Health Partners

Christine Ann Miller CEOMelinta Therapeutics

Chris Mortko, Ph.D., MBAVice President, Head Search & Evaluation Business Development & LicensingMerck & Co.

Tim OplerManaging DirectorGlobal Healthcare GroupStifel

Emilio RagosaPartner, Managing Partner, Short Hills, Global Co-Chair, Life Sciences and Healthcare SectorDLA Piper

MaryAnne Rizk, Ph.D.Head, Healthcare & Life Sciences, AIAmazon Web Services

Eduardo SchurUS Life SciencesCommercial Strategyand R&D LeadEY

Nauman ShahGlobal HeadInnovative MedicineBusiness DevelopmentJohnson & Johnson

Arda Ural, Ph.D.Americas Life Sciences LeaderEY

Thank You To Our Sponsors

2025 BioNJ Patient Advocacy Summit
2025-11-17 08:30 - 14:45 | Bristol Myers Squibb, 3401 Princeton Pike, Lawrence Township, NJ, 08648, United States
Registration is now closed for this event. We look forward to seeing confirmed registrants on Monday at Bristol Myers Squibb. Please contact Randi Bromberg at RBromberg@BioNJ.org with questions or to be added to the wait list.

The Power of the Patient’s Voice

Monday, November 17, 2025 • 8:30 a.m.-2:45 p.m. Bristol Myers Squibb, 3401 Princeton Pike, Lawrence Township

Attendance is only open and free to ALL Patient Advocacy Organizations and R&D company Patient advocacy and government affairs professionals.

Become a Sponsor

Join us for BioNJ’s 10th Annual Patient Advocacy Summit — a dynamic, educational gathering designed to leave you with new tools to make a meaningful difference on behalf of Patients. This empowering day will bring together Patients, Advocacy Groups, Care Partners, Clinicians, Policymakers and R&D Professionals to connect, share and collaborate around advancing Patient-centered care.

Why Attend?

Gain Tools You Can Use — whether you’re helping someone navigate coverage, understand a diagnosis or access treatment.

Make Your Voice Heard — join the conversation with healthcare leaders, researchers and policymakers to help shape the future of care from a Patient-first perspective.

Build Your Network — find community among others who truly understand the challenges and rewards of this work.

Be Inspired — through powerful stories of resilience, innovation and progress you’ll leave empowered and ready to take action.

Featuring topics requested by the Patient advocacy community and a diverse roster of speakers, we hope you join us for this important conversation!

Hot Topics on the Agenda:

Health Literacy― Helping Patients Understand and Engage in Their Care

Regulatory Process ― What Does the FDA Look Like

Medicaid in Motion ― Understanding & Managing Evolving Requirements

340B at a Crossroad ― Reform, Transparency & Accountability

Resilience, Reinvention & Relentless Advocacy ― Keynote by Rob Long, Executive Director of Uplifting Athletes

Hear from Experts Driving These Conversations:

Commissioner Sarah AdelmanNew Jersey Department of Human Services

Ruth P. Brogden, MPHCare Partner & DirectorPublic Health Programs & Grants Center for Asian Health & Liver CenterCooperman Barnabas Medical Center

Michael CalvoVice PresidentFederal Government AffairsBristol Myers Squibb

Kim Czubaruk, JDVice President, PolicyCancerCare

Jayne GershkowitzChief Patient Advocate EmeritaAmicus Therapeutics

Christopher Gilligan, M.D.Chief Medical & Quality OfficerRobert Wood Johnson University Hospital

Debbie HartPresident & CEOBioNJ

Erika Kerber, Esq.President & Executive DirectorCommunity Health Law Project

Rob LongExecutive DirectorUplifting Athletes

Ian McLaughlin, Ph.D.Senior Vice PresidentGovernment Affairs & PolicyBioNJ

Catina O’Leary, Ph.D.President & CEOHealth Literacy Media

Julie RaskinCo-founder & CEOCongenital Hyperinsulinism International (CHI)

Judy SaydahCare Partner for a Child with Rett Syndrome

William S. Smith, Ph.D.Senior Fellow & DirectorLife Sciences InitiativeThe Pioneer Institute

Julie TierneyFormer, Deputy Director, FDACenter for Biologics Evaluation & Research PrincipalLeavitt Partners

Reverend Kimberly L. WilliamsPresident & CEOChoose Healthy Life

Attendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.

Thank You to Our Sponsors

2025 BioNJ Inspiring STEM Conference
2025-12-04 08:30 - 15:00 | Genmab, 777 Scudders Mill Road, Plainsboro, NJ, 08536, United States
INFORM, INVOLVE, INSPIREIgniting Ideas & Advancing Bold Futures

Thursday, December 4, 2025 | 8:30 a.m.-3:00 p.m. Genmab, 777 Scudders Mill Road, Bldg. 2, 1st Floor, Plainsboro 08536Registration for BioNJ Members is $330 and $430 for Future Members.

Register Today!

Become a Sponsor

﻿BioNJ is thrilled to unveil the agenda for our upcoming Inspiring STEM Conference, taking place on Thursday, December 4!

Evolving from our highly regarded Inspiring Women in STEM Conference, this year’s expanded program is designed to engage and empower all professionals across the STEM spectrum — from early-career talent to senior leadership.

The full-day event features a thoughtfully curated agenda addressing the most pressing and forward-looking topics shaping the future of science, technology, engineering and math. With a focus on actionable insights, bold ideas and inclusive dialogue, the conference promises to engage and energize everyone committed to advancing the future of STEM.

From how AI is reshaping the STEM workforce to how the Gates Foundation is accelerating women’s health-focused R&D, this forward-thinking program will leave you informed, inspired and equipped to lead with impact in 2026 and beyond!

TimeCheck Out the Agenda

8:30 a.m. – 9:00 a.m.
Registration & Networking Breakfast

9:00 a.m. – 9:15 a.m.
Welcome & Opening Remarks

Debbie Hart, President & CEO, BioNJ
Marisol Mendez Peron, Senior Vice President, Communications & Corporate Affairs, Genmab

Time BE INFORMED: EDUCATIONAL TOPICS

9:15 a.m.– 10:15 a.m.
LEAP Beyond AI: Reinventing Leadership & Human IntelligenceKeynote by Micheline Nader, BSN, MPH, DESS, Author, Motivational Speaker & CEO, Jesra Foundation
In this powerful session, Ms. Nader will deliver a compelling blend of visionary insight and practical strategy, offering a framework for thriving in a tech-driven world while staying grounded in purpose and well-being. Attendees will explore how to:

Lead with confidence in an AI-enabled world
Achieve extraordinary, sustainable results
Unlock and elevate their inner genius
Prevent burnout and prioritize personal health
Build a leadership legacy that lasts

Walk away inspired, equipped and ready to lead boldly — with clarity, compassion and resilience.

10:15 a.m. – 10:45 a.m.
Networking Break & Exhibitor Showcase

10:45 a.m.– 11:45 a.m.
Panel: How AI is Reshaping Workforce Identity, Decision-Making and Leadership Priorities in STEM Fields
As AI rapidly transforms the STEM landscape, leaders face a new frontier of challenges — and opportunities. This session explores how artificial intelligence is reshaping workforce identity, decision-making processes, and leadership priorities across scientific, technical and clinical environments. Whether you're an executive, team leader or emerging professional, this session will offer practical insights on navigating change with confidence and clarity.Panelists:

Tahamtan Ahmadi, M.D., Ph.D., Executive Vice President and Chief Medical Officer, Head, Experimental Medicines, Genmab
Stephen K. Burley, M.D., D.Phil, Director, Rutgers Artificial Intelligence and Data Science (RAD) Collaboratory, Rutgers University
Rivers Cornelson, Senior AI Consulting Lead, Crowe
Tina Naser, Partner, Healthcare Life Sciences Industry, IBM
Moderated by Meghan Condon, Vice President, Digital & AI, Thermo Fisher Scientific

Time BE INVOLVED: INTERACTIVE TOPICS TO PROMOTE ACTIONABLE TAKEAWAYS/STEPS FOR ALL

11:45 a.m. – 12:15 p.m.
Imagining and Defining Our Relationship with AITo foster networking, collaboration, and idea-sharing, we’ll be facilitating fun table discussions over lunch. Topics will include:

Leadership & Personal Influence
Career Growth & Skill Development
Workplace & Collaboration
Health, Wellness & Personal Balance
Imagination & the Future of Work
Trust, Ethics & Responsibility

12:15 p.m. – 1:15 p.m.
Lunch, Table Discussions & Exhibitor ShowcaseDiscussion led by Lynne Anderson, Partner, Faegre Drinker and Juliet Hart, CEO & Founder, Hart & Chin

1:15 p.m. – 1:45 p.m.
Debrief on Table DiscussionsAfter lunch, we’ll reconvene for table readouts to share insights and examples on how AI can support our leadership, career growth, work relationships — and even our well-being.

TimeBE INSPIRED: INSIGHTS TO INSPIRE

1:45 p.m. – 2:45 p.m.
Sparking a New Era of Women-Centered Research and InnovationJoin us for a compelling conversation on the Gates Foundation’s landmark $2.5 billion commitment through 2030 to accelerate research and development focused exclusively on women’s health. This session will explore how the initiative aims to advance more than 40 innovations across five critical and historically underfunded areas — particularly those impacting women in low- and middle-income countries. Gain insight into the strategies, priorities, and transformative potential of this unprecedented investment in women’s health and well-being.
Panelists:

Katie Barletta M.D., Ph.D., FACOG, Senior Global Medical Director, Ferring Pharmaceutical
Ru Cheng, M.D., FACOG, Director, Women's Health Innovations, Gender Equality Division, Gates Foundation
Vrunda Desai, M.D., FACOG, Vice President, Medical Affairs & Clinical Surgery, CooperSurgical
Moderated by Elizabeth Garner, M.D., CEO, Sena Therapeutics

2:45 p.m. – 3:00 p.m.
Closing Remarks

Tahamtan Ahmadi, M.D., Ph.D.Executive Vice President and Chief Medical OfficerHead, Experimental MedicinesGenmab

Lynne AndersonPartnerFaegre Drinker

Katie Barletta M.D., Ph.D., FACOGSenior GlobalMedical DirectorFerring Pharmaceuticals

Stephen K. Burley, M.D., D.PhilDirector, Rutgers Artificial Intelligence and Data Science(RAD) Collaboratory, Rutgers University

Ru ChengM.D., FACOGDirectorWomen’s Health InnovationsGender Equality DivisionGates Foundation

Meghan CondonVice PresidentDigital & AIThermo Fisher Scientific

Christopher CozicExecutive Vice President & Chief People OfficerGenmab & BioNJ Board Member

Rivers CornelsonSenior AI Consulting LeadCrowe

Vrunda Desai, M.D., FACOGVice PresidentMedical Affairs & Clinical SurgeryCooperSurgical

Elizabeth Garner, MDCEOSena Therapeutics

Debbie HartPresident & CEOBioNJ

Juliet HartCEO & FounderHart & Chin

Micheline Nader, BSN, MPH, DESSAuthorMotivational Speaker & CEOJesra Foundation

Tina NaserPartner, Healthcare Life Sciences IndustryIBM

Register today and plan to join us at BioNJ’s STEM Conference on December 4, 2025. Registration for BioNJ Members is $330 and $430 for Future Members.

Click here or contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions.

2025 BioNJ Gives Back
2025-12-10 00:00 - 23:59 | Bristol Myers Squibb, 3401 Princeton Pike, Lawrence Township, NJ, 08648, United States
Exclusive to BioNJ Members Only

December 10, 2025

Become a Sponsor

Two times and locations:

9:00 a.m.-11:00 a.m.700 US Highway 202/206, Bridgewater

Register Today!

2:00 p.m.-4:00 p.m. M Station, 100 Morris Street, Morristown

Register Today!

Participants will have the opportunity to make a meaningful impact by assembling “Totes of Hope: Hospital Care Kits.” Volunteers will decorate a canvas tote bag with uplifting messages, inspiring artwork or colorful designs, then fill it with comforting essentials. Each tote becomes a heartfelt symbol of care and kindness, offering encouragement to Patients of all ages and conditions.

Our Totes of Hope will be distributed to Patients through RWJBarnabas Health/ Rutgers Cancer Institute and Inspira Health.

We hope you will join us!

Member companies can send up to three participants at no charge!* It’s the perfect opportunity to network with fellow BioNJ Members while making a difference on behalf of pediatric Patients.

We warmly invite your organization to consider sponsoring this meaningful community initiative in support of Patients across New Jersey. Please contact Randi Bromberg at RBromberg@BioNJ.org to learn more.

*Registration is on a first-come, first-served basis. Each location is limited to 150 volunteers.

Thank You to Our Sponsors
